UNSPSC 51281645: Dibekacin sulfate

This classification denotes an aminoglycoside antibiotic with the molecular formula C18H37N5O8.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A0869I992Z, chemically known as d-streptamine, o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-4))-2-deoxy-, sulfate (salt) but more generally known as dibekacin sulfate, which bears US NIH Compound Identifier 162862.

UNSPSC 51281645 Dibekacin sulfate is a Commodity code that nominally covers a specific aminoglycoside antibiotic, but the recent state and local procurement activity tagged under it does not reflect purchases of dibekacin itself. Instead, the opportunities show state and local health agencies procuring other pharmaceutical products — antibiotics (Doxycycline Hyclate, Ciprofloxacin Hydrochloride) and overdose-response medications (Naloxone) — through piggyback contracts and competitive bidding processes. State issuing bodies driving activity under this code include the Illinois Department of Public Health and county-level health authorities such as Seminole County, Florida. The scope of work involves sourcing generic and specialty pharmaceuticals for public health stockpiling, emergency response, and community health initiatives, with typical contract structures featuring 12- to 24-month terms, annual or quarterly delivery schedules, and fixed unit pricing.

Recent activity concentrates in Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse order to Chartwell Rx LLC through the MMCAP Infuse cooperative purchasing vehicle on August 28, 2026, under IFB 26482DPHPREPDB53392, covering Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets with a 12-month initial term and two one-year renewal options. Seminole County, Florida issued an IFB (60459723LAS) on June 30, 2026, seeking annual quantities of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building; the response deadline was July 26, 2023. Both opportunities required electronic submission, fixed-fee pricing, standard compliance certifications (drug-free workplace, E-Verify), and commercial insurance coverage. Neither procurement specified explicit small-business or minority-enterprise set-asides.